The Return of the Flu: Prevention and Management Beyond Vaccination in 2022

Download All
As we anticipate a resurgence of influenza activity during the 2022-2023 season, healthcare professionals must refocus on prevention and treatment in patients with rheumatologic diseases.
Cassandra Calabrese, DO
Tracy Zivin-Tutela, MD

It is recommended to treat with antivirals in cases of suspected or confirmed flu in outpatients who are at high risk of complications, and that includes our immunocompromised rheumatology patients.

Cassandra Calabrese, DO Released: December 2, 2022

Join an infectious diseases expert as she discusses postexposure chemoprophylaxis and influenza treatment for patients with rheumatologic disorders who are at high risk for complications.

Tracy Zivin-Tutela, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: December 9, 2022 Expired: No longer available for credit
Provided by Partners for Advancing Clinical Education, in partnership with Practicing Clinicians Exchange
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 
Supported by an educational grant from
Genentech, a member of the Roche Group

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings